loadpatents
name:-0.03124213218689
name:-0.029345035552979
name:-0.017595052719116
Ruprecht-Karls-Universitaet Heidelberg Patent Filings

Ruprecht-Karls-Universitaet Heidelberg

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ruprecht-Karls-Universitaet Heidelberg.The latest application filed is for "18f - tagged inhibitors of prostate specific membrane antigen (psma) and their use as imaging agents for prostate cancer".

Company Profile
18.36.28
  • Ruprecht-Karls-Universitaet Heidelberg - Heidelberg N/A DE
  • RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG - DE
  • Ruprecht-Karls-Universitaet Heidelberg - DE DE
  • RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG - Grabengrasse 1 Heidelberg DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Double-labeled probe for molecular imaging and use thereof
Grant 11,452,786 - Eder , et al. September 27, 2
2022-09-27
HMGB1 tyrosine mutants
Grant 11,072,641 - Gdynia July 27, 2
2021-07-27
Lipopeptides for use in treating liver diseases and cardiovascular diseases
Grant 10,967,044 - Cleeves , et al. April 6, 2
2021-04-06
18f - Tagged Inhibitors Of Prostate Specific Membrane Antigen (psma) And Their Use As Imaging Agents For Prostate Cancer
App 20210053922 - CARDINALE; Jens ;   et al.
2021-02-25
Lipopeptides for Use in Treating Liver Diseases and Cardiovascular Diseases
App 20200384070 - CLEEVES; Volker ;   et al.
2020-12-10
A Double-labeled Probe For Molecular Imaging And Use Thereof
App 20200368374 - EDER; Ann-Christin ;   et al.
2020-11-26
A Double-labeled Probe For Molecular Imaging And Use Thereof
App 20200353109 - EDER; Matthias ;   et al.
2020-11-12
18F--tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer
Grant 10,815,200 - Cardinale , et al. October 27, 2
2020-10-27
Development of HBV-and/or HDV-susceptible cells, cell lines and non-human animals
Grant 10,618,947 - Urban , et al.
2020-04-14
Use of parvovirus for eliminating cancer stem cells (CSCs)
Grant 10,525,091 - Rommelaere , et al. J
2020-01-07
Hmgb1 Mutants
App 20190352360 - GDYNIA; Georg
2019-11-21
Lipopeptides for use in treating liver diseases and cardiovascular diseases
Grant 10,413,585 - Cleeves , et al. Sept
2019-09-17
Means and methods for diagnosing heart failure in a subject
Grant 10,393,762 - Fuhrmann , et al. A
2019-08-27
Lipopeptides for Use in Treating Liver Diseases and Cardiovascular Diseases
App 20190151406 - CLEEVES; Volker ;   et al.
2019-05-23
Conjugates of proteins and multivalent cell-penetrating peptides and their uses
Grant 10,253,099 - Strieker , et al.
2019-04-09
Method and kit for assessment of sodium channel-related anti- or pro-arrhythmic potential of compounds
Grant 10,254,273 - Koenen , et al.
2019-04-09
Rna Viruses For Immunovirotherapy
App 20190099461 - UNGERECHTS; Guy ;   et al.
2019-04-04
Means And Methods For Differentiating Between Heart Failure And Pulmonary Disease In A Subject
App 20190064191 - SCHATZ; Philipp ;   et al.
2019-02-28
RNA viruses for immunovirotherapy
Grant 10,172,894 - Ungerechts , et al. J
2019-01-08
Therapeutic micro RNA targets in chronic pulmonary diseases
Grant 10,119,135 - Mall , et al. November 6, 2
2018-11-06
Parovirus having a CpG-enriched genome useful for cancer therapy
Grant 10,098,917 - Raykov , et al. October 16, 2
2018-10-16
Co-administration of a parvovirus and a cytokine for therapy of pancreatic cancer
Grant 10,058,591 - Raykov , et al. August 28, 2
2018-08-28
Neutron detector unit and neutron detector arrangement
Grant 10,024,986 - Lennert , et al. July 17, 2
2018-07-17
18f - Tagged Inhibitors Of Prostate Specific Membrane Antigen (psma) And Their Use As Imaging Agents For Prostate Cancer
App 20180194729 - CARDINALE; Jens ;   et al.
2018-07-12
Histone Anti-cancer Vaccines
App 20180155403 - PLATTEN; Michael ;   et al.
2018-06-07
Treatment of insulin resistance through inhibitors of transcription factor TSC22D4
Grant 9,879,258 - Berriel Diaz , et al. January 30, 2
2018-01-30
Oncolytic virotherapy for prevention of tumor recurrence
Grant 9,861,669 - Rommelaere , et al. January 9, 2
2018-01-09
Method for blocking HIV entry into dendritic cells by inhibiting sialoadhesin-sialyllactose binding interactions with gangliosides
Grant 9,789,130 - Izquierdo Useros , et al. October 17, 2
2017-10-17
USE OF PARVOVIRUS FOR ELIMINATING CANCER STEM CELLS (CSCs)
App 20170266244 - Rommelaere; Jean ;   et al.
2017-09-21
Method And Enzyme Solution For Flow-cytometric Detection Of Light Chain Restriction
App 20170204450 - KRIENKE; Stefan ;   et al.
2017-07-20
Use of parvovirus for eliminating cancer stem cells (CSCs)
Grant 9,700,588 - Rommelaere , et al. July 11, 2
2017-07-11
Methods of treating cancer using chemovirotherapy
Grant 9,664,684 - Giese , et al. May 30, 2
2017-05-30
Rna Viruses For Immunovirotherapy
App 20170128505 - UNGERECHTS; Guy ;   et al.
2017-05-11
p16.sup.INK4a derived peptides for prophylaxis and therapy of HPV-associated tumors and other p16.sup.INK4a expressing tumors
Grant 9,566,319 - Kloor , et al. February 14, 2
2017-02-14
Method for Cancer Therapy Based on Co-Administration of a Parvovirus and a Cytokine
App 20160367609 - KIPRIJANOVA; Irina ;   et al.
2016-12-22
FIB-SEM array tomography
Grant 9,464,995 - Edelmann , et al. October 11, 2
2016-10-11
Method for brain cancer therapy by co-administration of a parvovirus and interferon-gamma
Grant 9,446,099 - Kiprijanova , et al. September 20, 2
2016-09-20
Co-Administration of a Parvovirus and a Cytokine for Therapy of Pancreatic Cancer
App 20160082085 - RAYKOV; Zahari ;   et al.
2016-03-24
Post-synthetic modification of nucleic acids by inverse diels-alder reaction
Grant 9,169,283 - Wiessler , et al. October 27, 2
2015-10-27
Development Of Hbv-and/or Hdv-susceptible Cells, Cell Lines And Non-human Animals
App 20150299289 - Urban; Stephan ;   et al.
2015-10-22
P16.sup.INK4A derived peptides for prophylaxis and therapy of HPV-associated tumors and other P16.sup.INK4A expressing tumors
Grant 9,114,101 - Kloor , et al. August 25, 2
2015-08-25
Gpr177 as target and marker in tumors
Grant 9,062,114 - Boutros , et al. June 23, 2
2015-06-23
Therapeutic Micro Rna Targets In Chronic Pulmonary Diseases
App 20150140067 - Mall; Marcus ;   et al.
2015-05-21
Fib-sem Array Tomography
App 20150036122 - Edelmann; Martin ;   et al.
2015-02-05
Robot For Holding And For Handling Medical Instruments And Equipment
App 20150038980 - Merscher; Michael ;   et al.
2015-02-05
Co-Administration of a Parvovirus and a Cytokine for Therapy of Pancreatic Cancer
App 20140328798 - Raykov; Zahari ;   et al.
2014-11-06
Parvovirus Cancer Therapy and Combination with Chemotherapy
App 20140234261 - ROMMELAERE; Jean ;   et al.
2014-08-21
Gpr177 As Target And Marker In Tumors
App 20140227276 - Boutros; Michael ;   et al.
2014-08-14
Parvovirus having a CPG-enriched genome useful for cancer therapy
Grant 8,535,929 - Raykov , et al. September 17, 2
2013-09-17
Parvovirus cancer therapy and combination with chemotherapy
Grant 8,414,883 - Rommelaere , et al. April 9, 2
2013-04-09
Method to derive anatomical and/or pathological structures from data of imaging technologies
Grant 8,369,925 - Giesel , et al. February 5, 2
2013-02-05
Oncolytic Virotherapy for Prevention of Tumor Recurrence
App 20120237483 - Rommelaere; Jean ;   et al.
2012-09-20
Intubation Tube
App 20110004065 - SCHRAMM; Christoph
2011-01-06
Intubation Tube
App 20100210907 - SCHRAMM; Christoph
2010-08-19
Method for the Microscopic Localization of a Selected, Intracellular DNA Segment with a Known Nucleotide Sequence
App 20090130686 - Hausmann; Michael ;   et al.
2009-05-21
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed